Reproductive Toxicology of Boron Analogs of Biomolecules

Award Information
Agency:
Department of Health and Human Services
Branch
n/a
Amount:
$73,004.00
Award Year:
1994
Program:
SBIR
Phase:
Phase I
Contract:
1 R43 HD31393-1,
Agency Tracking Number:
24953
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
Boron Biologicals, Inc.
620 Hutton Street, Suite 104, Raleigh, NC, 27606
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
n/a
Principal Investigator:
Bernard Spielvogel
(919) 832-2044
Business Contact:
() -
Research Institution:
n/a
Abstract
Boron analogs of biomolecules exhibit considerable therapeutic potential in the areas of cancertreatment, bone disorder (such as osteoporosis), hyperlipidemia and inflammation. Considerable activityhas been demonstrated in cell cultures and rodent models. Most of the agents tested for acute toxicityappear to be safe. Considering, however, the reproductive and endocrine toxicity of boric acid (and itsborate salts), it its important to determine whether boron analogs of biomolecules exhibit similar toxicity.The Phase I studies will focus on synthetic methods development (to produce large quantities ofmaterials for toxicity studies), development of bioassays for determining testicular and endocrine effects,and screening of compounds using the newly developed bioassays. In Phase II studies, compounds willbe tested for endocrine lesions using the rapid endocrine bioassay and to determine their relativeimportance for drug development. This toxicity information, combined with the pharmacological activityalready observed, will then enable us to continue the development of pharmacologically active boroncompounds.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government